A Handheld Quantifiable Soft Tissue Manipulation Device for Tracking Real-Time Dispersive Force-Motion Patterns to Characterize Manual Therapy Treatment.

A Handheld Quantifiable Soft Tissue Manipulation Device for Tracking Real-Time Dispersive Force-Motion Patterns to Characterize Manual Therapy Treatment.
复制标题

DOI:
10.1109/tbme.2022.3222124
复制
发表时间:
2023-05
期刊:
IEEE transactions on bio-medical engineering
影响因子:
--
通讯作者:
--
中科院分区:
其他
文献类型:
--
作者:

文献摘要

参考文献

相似文献

下背痛(LBP)是地球仪的主要神经肌肉骨骼(NMSK)问题之一。软组织操作(STM)是一种基于力的非侵入性干预,用于临床解决NMSK疼痛状况。目前的STM实践标准大多是主观的,这表明迫切需要定量度量。本研究旨在开发一种手持式便携式智能医疗设备,用于跟踪实时分散的力运动,以将手动治疗治疗表征为可量化的软组织操作(QSTM)。该设备包括两个3D测力传感器,用于量化压缩力和平面剪切力,以及一个6自由度IMU传感器,用于在扫描和移动身体较大区域的肌筋膜限制时采集自愿适应的治疗运动。作为PC软件(Q-Ware©)后处理的一部分,这些力-运动用治疗参数(目标力、应用角度、速率、方向、运动模式、时间)表征QSTM。进行了一项人体病例研究,将LBP视为器械临床可用性的概念验证。治疗参数的外部确认报告了临床使用所需的适当器械精度。病例研究结果显示,治疗中可识别的治疗力-运动模式表明受试者的力-耐力提高,自我报告疼痛减轻。QSTM指标可以使得能够使用可记录的手动治疗来研究STM给药以优化疼痛减轻和功能结局。临床试验将进一步确定其可靠性和与传统STM的比较。这种医疗器械技术不仅通过精确康复推进了最先进的手动治疗,而且还通过可重复性增强了实践,以检查NMSK病理学的个体化STM处方的神经生物学反应。
Low back pain (LBP) is one of the leading neuromusculoskeletal (NMSK) problems around the globe. Soft Tissue Manipulation (STM) is a force-based, non-invasive intervention used to clinically address NMSK pain conditions. Current STM practice standards are mostly subjective, suggesting an urgent need for quantitative metrics. This research aims at developing a handheld, portable smart medical device for tracking real-time dispersive force-motions to characterize manual therapy treatments as Quantifiable Soft Tissue Manipulation (QSTM). The device includes two 3D load-cells to quantify compressive and planar-shear forces, coupled with a 6 degrees-of-freedom IMU sensor for acquiring volitionally adapted therapeutic motions while scanning and mobilizing myofascial restrictions over larger areas of the body. These force-motions characterize QSTM with treatment parameters (targeted force, application angle, rate, direction, motion pattern, time) as a part of post-processing on a PC software (Q-Ware©). A human case study was conducted to treat LBP as proof-of-concept for the device’s clinical usability. External validation of treatment parameters reported adequate device precision required for clinical use. The case study findings revealed identifiable therapeutic force-motion patterns within treatments indicating subject’s elevated force-endurance with self-reported pain reduction. QSTM metrics may enable study of STM dosing for optimized pain reduction and functional outcomes using documentable manual therapy. Clinical trials will further determine its reliability and comparison to conventional STM. This medical device technology not only advances the state-of-the-art manual therapy with precision rehabilitation but also augments practice with reproducibility to examine neurobiological responses of individualized STM prescriptions for NMSK pathology.
DOI: 10.1007/s10439-013-0886-3
发表时间: 2014-01
影响因子: 3.8
作者:
Wang, Qian;Zeng, Hansong;Best, Thomas M.;Haas, Caroline;Heffner, Ned T.;Agarwal, Sudha;Zhao, Yi
通讯作者: Zhao, Yi